PL2561880T3 - Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające - Google Patents
Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierająceInfo
- Publication number
- PL2561880T3 PL2561880T3 PL12178634T PL12178634T PL2561880T3 PL 2561880 T3 PL2561880 T3 PL 2561880T3 PL 12178634 T PL12178634 T PL 12178634T PL 12178634 T PL12178634 T PL 12178634T PL 2561880 T3 PL2561880 T3 PL 2561880T3
- Authority
- PL
- Poland
- Prior art keywords
- lactic acid
- compositions containing
- acid bacteria
- containing same
- probiotic strains
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 241000894006 Bacteria Species 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2004011980 | 2004-10-22 | ||
EP2004011981 | 2004-10-22 | ||
EP2005001354 | 2005-02-10 | ||
EP12178634.7A EP2561880B1 (en) | 2004-10-22 | 2005-10-17 | Lactic acid bacteria as probiotic strains and compositions containing same |
EP05795238A EP1812023B8 (en) | 2004-10-22 | 2005-10-17 | Lactic acid bacteria as probiotic strains and compositions containing same |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2561880T3 true PL2561880T3 (pl) | 2015-02-27 |
Family
ID=35534903
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12178634T PL2561880T3 (pl) | 2004-10-22 | 2005-10-17 | Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające |
PL05795238T PL1812023T3 (pl) | 2004-10-22 | 2005-10-17 | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05795238T PL1812023T3 (pl) | 2004-10-22 | 2005-10-17 | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające |
Country Status (7)
Country | Link |
---|---|
US (4) | US20100196340A1 (pl) |
EP (3) | EP2561880B1 (pl) |
JP (1) | JP2008517014A (pl) |
DK (1) | DK2561880T3 (pl) |
ES (2) | ES2392172T3 (pl) |
PL (2) | PL2561880T3 (pl) |
WO (3) | WO2006045347A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1802318A1 (en) * | 2004-10-22 | 2007-07-04 | Medinova AG | Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same |
EP2206506A1 (en) * | 2008-12-18 | 2010-07-14 | Bracco Imaging S.p.A | Probiotic formulations |
BG66608B1 (bg) * | 2011-05-04 | 2017-10-16 | "Ел Би Булгарикум" ЕАД | Полибактериален пробиотичен препарат |
FR2992861B1 (fr) | 2012-07-09 | 2014-10-17 | Probionov | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
FR2992973B1 (fr) | 2012-07-09 | 2015-12-18 | S P M D | Nouvelle souche de lactobacillus crispatus |
CN103911306B (zh) * | 2013-01-05 | 2016-08-24 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
CN103911309B (zh) * | 2013-01-05 | 2016-08-24 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
EP3064072A1 (en) * | 2015-02-11 | 2016-09-07 | AB-Biotics S.A. | Probiotic lactobacillus strains for use in treating urinary tract infections |
FR3048361B1 (fr) | 2016-03-01 | 2020-12-18 | Biose | Compositions pour le traitement des candidoses |
GB2557823A (en) * | 2016-03-04 | 2018-06-27 | Univ California | Microbial consortium and uses thereof |
EP3512532A1 (en) * | 2016-09-16 | 2019-07-24 | DuPont Nutrition Biosciences ApS | Bacteria |
JP6990660B2 (ja) * | 2016-10-20 | 2022-01-12 | ビオフェルミン製薬株式会社 | 腸管のイオン経細胞輸送体への作用剤、クロライドチャネル活性化剤、腎疾患の予防もしくは治療剤、又は排便促進剤 |
AU2017368922A1 (en) | 2016-11-30 | 2019-05-30 | Probioswiss Ag | Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid |
EP3427745A1 (en) * | 2017-07-12 | 2019-01-16 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | New probiotic composition for prevention of bacterial vaginosis |
WO2019199895A1 (en) | 2018-04-10 | 2019-10-17 | Siolta Therapeutics, Inc. | Microbial consortia |
WO2021071864A1 (en) | 2019-10-07 | 2021-04-15 | Siolta Therapeutics, Inc. | Therapeutic pharmaceutical compositions |
US11850303B2 (en) * | 2020-10-27 | 2023-12-26 | Uqora, Inc. | Gel and a suppository and methods to provide the gel and suppository |
KR102337951B1 (ko) * | 2021-06-25 | 2021-12-13 | 주식회사 비피도 | 요로감염 개선, 예방 또는 치료를 위한 락토바실러스 헬베티쿠스 gut10 균주 및 이를 포함하는 조성물 |
CN114717169B (zh) * | 2022-06-10 | 2022-08-23 | 南京益瑞兰生物科技有限公司 | 一种瑞士乳杆菌及其在制备调节生殖道微生态和缓解生殖道干涩产品中的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1234567A (en) * | 1915-09-14 | 1917-07-24 | Edward J Quigley | Soft collar. |
DK242083D0 (da) * | 1983-05-27 | 1983-05-27 | Hansens Chr Bio Syst | Vaginalkapsler |
IT1227154B (it) * | 1988-08-05 | 1991-03-19 | A Tosi Farmaceutici S R L Nova | Composizioni farmaceutiche per uso ginecologico a base di lattobacilli |
SE8900546D0 (sv) * | 1989-02-17 | 1989-02-17 | Bioinvent Int Ab | Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
ES2165139T3 (es) * | 1998-04-30 | 2002-03-01 | Vesely Renata Maria Cavaliere | Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales. |
EP1082964A1 (en) * | 1998-06-05 | 2001-03-14 | Wakamoto Pharmaceutical Co., Ltd. | Lactic acid bacterium-containing compositions, drugs and foods |
TR200101699T2 (tr) * | 1998-12-11 | 2002-06-21 | Urex Biotech, Inc. | Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması |
CA2374937A1 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
SE521022C2 (sv) * | 2001-09-20 | 2003-09-23 | Ellen Ab | Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa |
JP2002193817A (ja) * | 2000-12-28 | 2002-07-10 | Calpis Co Ltd | 整腸剤 |
ATE409220T1 (de) * | 2002-03-21 | 2008-10-15 | Bifodan As | Lactobacillus-stämme |
AU2003215472A1 (en) * | 2002-03-28 | 2003-10-13 | Jeremy Burton | Lactobacillus iners for the enhancement of urogenital health |
US20040071679A1 (en) * | 2002-10-15 | 2004-04-15 | Claudio De Simone | Identifying and treating vaginal infections |
EP1802318A1 (en) * | 2004-10-22 | 2007-07-04 | Medinova AG | Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same |
-
2005
- 2005-02-22 WO PCT/EP2005/001846 patent/WO2006045347A1/en active Application Filing
- 2005-10-17 DK DK12178634.7T patent/DK2561880T3/da active
- 2005-10-17 WO PCT/EP2005/011150 patent/WO2006045473A1/en active Application Filing
- 2005-10-17 PL PL12178634T patent/PL2561880T3/pl unknown
- 2005-10-17 JP JP2007537179A patent/JP2008517014A/ja active Pending
- 2005-10-17 EP EP12178634.7A patent/EP2561880B1/en active Active
- 2005-10-17 PL PL05795238T patent/PL1812023T3/pl unknown
- 2005-10-17 US US11/577,680 patent/US20100196340A1/en not_active Abandoned
- 2005-10-17 ES ES05795238T patent/ES2392172T3/es active Active
- 2005-10-17 EP EP05795238A patent/EP1812023B8/en active Active
- 2005-10-17 EP EP05795969A patent/EP1802319A1/en not_active Withdrawn
- 2005-10-17 ES ES12178634.7T patent/ES2524432T3/es active Active
- 2005-10-17 WO PCT/EP2005/011152 patent/WO2006045475A1/en active Search and Examination
-
2007
- 2007-04-20 US US11/738,102 patent/US20080019954A1/en not_active Abandoned
-
2016
- 2016-10-12 US US15/291,880 patent/US10213466B2/en active Active
-
2019
- 2019-01-14 US US16/247,453 patent/US11040076B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2561880B1 (en) | 2014-08-27 |
PL1812023T3 (pl) | 2013-03-29 |
EP1812023B1 (en) | 2012-08-01 |
EP1802319A1 (en) | 2007-07-04 |
US11040076B2 (en) | 2021-06-22 |
WO2006045475A1 (en) | 2006-05-04 |
US20190142878A1 (en) | 2019-05-16 |
WO2006045347A1 (en) | 2006-05-04 |
US20100196340A1 (en) | 2010-08-05 |
EP1812023B8 (en) | 2012-12-26 |
ES2524432T3 (es) | 2014-12-09 |
US20080019954A1 (en) | 2008-01-24 |
WO2006045473A1 (en) | 2006-05-04 |
US10213466B2 (en) | 2019-02-26 |
JP2008517014A (ja) | 2008-05-22 |
EP2561880A3 (en) | 2013-06-19 |
US20170027998A1 (en) | 2017-02-02 |
DK2561880T3 (da) | 2014-10-27 |
ES2392172T3 (es) | 2012-12-05 |
EP2561880A2 (en) | 2013-02-27 |
EP1812023A1 (en) | 2007-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL178686A (en) | Preparations of bacterial strain of lactic acid and their uses | |
PL1812023T3 (pl) | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające | |
PT2548455T (pt) | Composição contendo uma bactéria de ácido láctico produzindo equol | |
IL173692A0 (en) | Bacterial strains, compositions including same and probiotic use thereof | |
SI1931363T1 (sl) | Zdravljenje vnetnih črevesnih bolezni z uporabo probiotičnih bakterij in fermentiranega žita kot efektorjev zdravljenja | |
IL184555A0 (en) | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough | |
EP1941892A3 (en) | Anti-allergy lactic acid bacteria | |
HK1160172A1 (en) | Lactic acid bacteria fermented substance and fermented milk food product containing the same | |
PL1824500T3 (pl) | Probiotyczne szczepy Lactobacillus dla polepszenia stanu zdrowia pochwy | |
IL202386A0 (en) | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis | |
ZA200908722B (en) | Freeze-dried,aerated dairy or diary-substitute compositions and methods of making thereof | |
IL200407A0 (en) | Stable digestive enzyme compositions, methods of producing the same and uses thereof | |
EP1661983A4 (en) | LACTIC FERMENT CAPABLE OF IMMUNOPOTENTIALIZATION OF MUCOUS MEMBRANES | |
HK1115730A1 (en) | Selection and use of lactic acid bacteria for reducing inflammation in mammals | |
ZA200908804B (en) | Composition comprising bacteria and lecithin | |
IL189610A0 (en) | Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria | |
HK1120421A1 (en) | Compositions and their preparation methods for inhibiting gastric acid secretion | |
EP1988155A4 (en) | LACTIC ACID BACTERIUM CAPABLE OF PRODUCING AMINO-ACUTE ACID | |
HK1116402A1 (en) | Lactic bacteria and their use in the prevention of diarrhea | |
AU2003255142A1 (en) | Composition containing ground lotus and/or lotus extract and lactic acid bacterium | |
WO2009099562A3 (en) | Compositions and methods for cleaning surfaces | |
PL1986502T3 (pl) | Składniki aromatyzujące i metoda aromatyzacji produktów mlecznych, szczep bakterii mlekowych, zastosowanie powyższych składników, metody lub szczepu | |
AP2007004168A0 (en) | Bacteriocins and novel bacterial strains | |
HK1132659A1 (en) | Method and use of lactic acid bacteria with increased acid tolerance | |
EP2196533A4 (en) | NEW MICROORGANISM WITH MAGENTA-LEADING EFFECT AND SEPARATE COMPOSITION |